Detalles de la búsqueda
1.
Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial.
Respir Res
; 23(1): 26, 2022 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35144620
2.
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma.
Pulm Pharmacol Ther
; 70: 102068, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34329722
3.
Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects.
BMC Pulm Med
; 21(1): 18, 2021 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33413291
4.
Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patients.
Respir Res
; 21(1): 248, 2020 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32967685
5.
Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study.
Respir Res
; 21(1): 87, 2020 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32295593
6.
Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once-daily inhalation as a combination in healthy subjects.
Pulm Pharmacol Ther
; 64: 101964, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33035700
7.
A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma.
Pulm Pharmacol Ther
; 62: 101919, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32387408
8.
Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial.
Am J Respir Crit Care Med
; 199(3): 313-320, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30095981
9.
Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial.
Am J Respir Crit Care Med
; 199(9): 1086-1096, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30641027
10.
Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes.
Pulm Pharmacol Ther
; 57: 101809, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31195091
11.
Corrigendum to "Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma" [Pulm. Pharmacol. Therapeut. 70 (2021) 102068].
Pulm Pharmacol Ther
; 73-74: 102126, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422377
12.
Pharmacokinetics and safety of indacaterol and glycopyrronium (IND/GLY) following repeated once daily inhalation from a fixed-dose combination in healthy Chinese subjectsâ©.
Int J Clin Pharmacol Ther
; 55(2): 147-155, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27841152
13.
Pharmacokinetic and Pharmacodynamic Characteristics of Subcutaneously Applied PTH-1-37.
Kidney Blood Press Res
; 41(5): 507-518, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27487342
14.
Population pharmacokinetics of IND/GLY (indacaterol/glycopyrronium) in COPD patients.
Int J Clin Pharmacol Ther
; 54(6): 405-15, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27049057
15.
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma.
J Asthma Allergy
; 16: 123-134, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36714049
16.
A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma.
Adv Ther
; 39(6): 2365-2378, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35072888
17.
Population Pharmacokinetic Analysis of Indacaterol/Glycopyrronium/Mometasone Furoate After Administration of Combination Therapies Using the Breezhaler® Device in Patients with Asthma.
Eur J Drug Metab Pharmacokinet
; 46(4): 487-504, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34024035
18.
Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial.
ERJ Open Res
; 7(2)2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33898609
19.
Opportunities and Challenges in Developing a Cryptosporidium Controlled Human Infection Model for Testing Antiparasitic Agents.
ACS Infect Dis
; 7(5): 959-968, 2021 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33822577
20.
Intravascular inactivation of CCR5 by n-Nonanoyl-CC chemokine ligand 14 and inhibition of allergic airway inflammation.
J Leukoc Biol
; 83(3): 765-73, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18063698